MedPath

Tripibra

Brand Name: Tripibra

Generic Name: Fenofibrate

Active
Registration Number

DRP-4838-02

Dosage Form

Capsule

Issuance Date

October 31, 2023

Expiry Date

October 16, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength200 mg
PackagingAlu/Clear PVC Blister Pack x 10's (Box of 30's, 50's, and 100's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Lipid Modifying Agent (Fibrates)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

FenofibrateActive
Monograph: Fenofibrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform